Alexis L. Beatty

Alexis L. Beatty

Auto-generated profile, based on publicly available information

Alexis L. Beatty

Division of Cardiology, Department of Medicine (M.M.M., A.L.B.), University of California, San Francisco

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2019 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
MPMarco V. Perez
Marco V. Perez
KMKenneth W. Mahaffey
Kenneth W. Mahaffey
HHHaley Hedlin
Haley Hedlin
JRJohn S. Rumsfeld
John S. Rumsfeld
AGAriadna Garcia
Ariadna Garcia
MTMintu P. Turakhia
Mintu P. Turakhia
Optical sensors on wearable devices can detect irregular pulses. The ability of a smartwatch application (app) to identify atrial fibrillation during typical use is unknown. Participants without atrial fibrillation (as reported by the participants themselves) used a smartphone (Apple iPhone) app to consent to monitoring. If a smartwatch-based irregular pulse notification algorithm identified possible atrial fibrillation, a telemedicine visit was initiated and an electrocardiography (ECG) patch was mailed to the participant, to be worn for up to 7 days. Surveys were administered 90 days after notification of the irregular pulse and at the end of the study. The main objectives were to estimate the proportion of notified participants with atrial fibrillation shown on an ECG patch and the positive predictive value of irregular pulse intervals with a targeted confidence interval width of 0.10. We recruited 419,297 participants over 8 months. Over a median of 117 days of monitoring, 2161 participants (0.52%) received notifications of irregular pulse. Among the 450 participants who returned ECG patches containing data that could be analyzed — which had been applied, on average, 13 days after notification — atrial fibrillation was present in 34% (97.5% confidence interval [CI], 29 to 39) overall and in 35% (97.5% CI, 27 to 43) of participants 65 years of age or older. Among participants who were notified of an irregular pulse, the positive predictive value was 0.84 (95% CI, 0.76 to 0.92) for observing atrial fibrillation on the ECG simultaneously with a subsequent irregular pulse notification and 0.71 (97.5% CI, 0.69 to 0.74) for observing atrial fibrillation on the ECG simultaneously with a subsequent irregular tachogram. Of 1376 notified participants who returned a 90-day survey, 57% contacted health care providers outside the study. There were no reports of serious app-related adverse events. The probability of receiving an irregular pulse notification was low. Among participants who received notification of an irregular pulse, 34% had atrial fibrillation on subsequent ECG patch readings and 84% of notifications were concordant with atrial fibrillation. This siteless (no on-site visits were required for the participants), pragmatic study design provides a foundation for large-scale pragmatic studies in which outcomes or adherence can be reliably assessed with user-owned devices. (Funded by Apple; Apple Heart Study ClinicalTrials.gov number, NCT03335800.)

2 July 2019 in Circulation
Verified
Journal Article
Closed access
PDF file
RTRandal J. Thomas
Randal J. Thomas
ABAlexis L. Beatty
Alexis L. Beatty
TBTheresa M. Beckie
Theresa M. Beckie
LBLaPrincess C. Brewer
LaPrincess C. Brewer
TBTodd M. Brown
Todd M. Brown
MWMary A. Whooley
Mary A. Whooley
Cardiac rehabilitation (CR) is an evidence-based intervention that uses patient education, health behavior modification, and exercise training to improve secondary prevention outcomes in patients with cardiovascular disease. CR programs reduce morbidity and mortality rates in adults with ischemic heart disease, heart failure, or cardiac surgery but are significantly underused, with only a minority of eligible patients participating in CR in the United States. New delivery strategies are urgently needed to improve participation. One potential strategy is home-based CR (HBCR). In contrast to center-based CR services, which are provided in a medically supervised facility, HBCR relies on remote coaching with indirect exercise supervision and is provided mostly or entirely outside of the traditional center-based setting. Although HBCR has been successfully deployed in the United Kingdom, Canada, and other countries, most US healthcare organizations have little to no experience with such programs. The purpose of this scientific statement is to identify the core components, efficacy, strengths, limitations, evidence gaps, and research necessary to guide the future delivery of HBCR in the United States. Previous randomized trials have generated low- to moderate-strength evidence that HBCR and center-based CR can achieve similar improvements in 3- to 12-month clinical outcomes. Although HBCR appears to hold promise in expanding the use of CR to eligible patients, additional research and demonstration projects are needed to clarify, strengthen, and extend the HBCR evidence base for key subgroups, including older adults, women, underrepresented minority groups, and other higher-risk and understudied groups. In the interim, we conclude that HBCR may be a reasonable option for selected clinically stable low- to moderate-risk patients who are eligible for CR but cannot attend a traditional center-based CR program.

22 December 2021 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
ABAlexis L. Beatty
Alexis L. Beatty
NPNoah D. Peyser
Noah D. Peyser
XBXochitl E. Butcher
Xochitl E. Butcher
JCJennifer M. Cocohoba
Jennifer M. Cocohoba
FLFeng Lin
Feng Lin
GMGregory M. Marcus
Gregory M. Marcus
In December 2020, the first COVID-19 vaccines received emergency use authorization in the United States.1,2 Billions of doses of vaccine have been administered worldwide.3 However, some individuals have concerns about receiving COVID-19 vaccination related to vaccine safety and adverse effects.4

17 January 2023 in Circulation
Verified
Journal Article
Open access
ABAlexis L. Beatty
Alexis L. Beatty
TBTheresa M. Beckie
Theresa M. Beckie
JDJohn Dodson
John Dodson
CGCarly M. Goldstein
Carly M. Goldstein
JHJoel W. Hughes
Joel W. Hughes
BFBarry A. Franklin
Barry A. Franklin
Cardiac rehabilitation (CR) is a guideline-recommended, multidisciplinary program of exercise training, risk factor management, and psychosocial counseling for people with cardiovascular disease (CVD) that is beneficial but underused and with substantial disparities in referral, access, and participation. The emergence of new virtual and remote delivery models has the potential to improve access to and participation in CR and ultimately improve outcomes for people with CVD. Although data suggest that new delivery models for CR have safety and efficacy similar to traditional in-person CR, questions remain regarding which participants are most likely to benefit from these models, how and where such programs should be delivered, and their effect on outcomes in diverse populations. In this review, we describe important gaps in evidence, identify relevant research questions, and propose strategies for addressing them. We highlight 4 research priorities: (1) including diverse populations in all CR research; (2) leveraging implementation methodologies to enhance equitable delivery of CR; (3) clarifying which populations are most likely to benefit from virtual and remote CR; and (4) comparing traditional in-person CR with virtual and remote CR in diverse populations using multicenter studies of important clinical, psychosocial, and cost-effectiveness outcomes that are relevant to patients, caregivers, providers, health systems, and payors. By framing these important questions, we hope to advance toward a goal of delivering high-quality CR to as many people as possible to improve outcomes in those with CVD.

18 November 2013 in Journal of the American Heart Association
Verified
Journal Article
Open access
ABAlexis L. Beatty
Alexis L. Beatty
YFYoshimi Fukuoka
Yoshimi Fukuoka
MWMary A. Whooley
Mary A. Whooley

23 July 2012 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
ABAlexis L. Beatty
Alexis L. Beatty
NSNelson B. Schiller
Nelson B. Schiller
MWMary A. Whooley
Mary A. Whooley
For patients with stable coronary heart disease (CHD), prognostic models based on traditional cardiovascular disease risk factors do not fully explain the risk of future cardiovascular events.1-3 Exercise treadmill testing provides information regarding prognosis in patients with stable CHD,4-9 but testing can be costly and time-consuming, especially if testing is bundled with imaging studies that may be unnecessary in stable patients.10-12